DE60036640T2 - Mittel zum stimulieren von körpergewichtzunahme, verfahren und produkt - Google Patents

Mittel zum stimulieren von körpergewichtzunahme, verfahren und produkt Download PDF

Info

Publication number
DE60036640T2
DE60036640T2 DE60036640T DE60036640T DE60036640T2 DE 60036640 T2 DE60036640 T2 DE 60036640T2 DE 60036640 T DE60036640 T DE 60036640T DE 60036640 T DE60036640 T DE 60036640T DE 60036640 T2 DE60036640 T2 DE 60036640T2
Authority
DE
Germany
Prior art keywords
weight
use according
medicament
trien
norpregna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036640T
Other languages
German (de)
English (en)
Other versions
DE60036640D1 (de
Inventor
David L. Atherton BERLINER
Louis Mountain View MONTI
Clive L. Salt Lake City JENNINGS-WHITE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pherin Pharmaceuticals Inc
Original Assignee
Pherin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharmaceuticals Inc filed Critical Pherin Pharmaceuticals Inc
Publication of DE60036640D1 publication Critical patent/DE60036640D1/de
Application granted granted Critical
Publication of DE60036640T2 publication Critical patent/DE60036640T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60036640T 1999-12-30 2000-12-28 Mittel zum stimulieren von körpergewichtzunahme, verfahren und produkt Expired - Lifetime DE60036640T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US475328 1999-12-30
US09/475,328 US6555531B1 (en) 1999-12-30 1999-12-30 Weight promoting composition, method, and product
PCT/US2000/035573 WO2001049280A2 (en) 1999-12-30 2000-12-28 Weight promoting composition, method, and product

Publications (2)

Publication Number Publication Date
DE60036640D1 DE60036640D1 (de) 2007-11-15
DE60036640T2 true DE60036640T2 (de) 2008-07-03

Family

ID=23887094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036640T Expired - Lifetime DE60036640T2 (de) 1999-12-30 2000-12-28 Mittel zum stimulieren von körpergewichtzunahme, verfahren und produkt

Country Status (11)

Country Link
US (1) US6555531B1 (enExample)
EP (1) EP1244458B1 (enExample)
JP (1) JP2003519179A (enExample)
AR (1) AR027136A1 (enExample)
AT (1) ATE374613T1 (enExample)
AU (1) AU2463301A (enExample)
CA (1) CA2394079C (enExample)
DE (1) DE60036640T2 (enExample)
ES (1) ES2292495T3 (enExample)
MX (1) MXPA02006568A (enExample)
WO (1) WO2001049280A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2008434A3 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917831A (en) * 1972-03-20 1975-11-04 Richardson Merrell Inc 3-Keto-7 {60 ,{62 -loweralkyl-{66 {0 5-steroids
US3946052A (en) * 1975-06-16 1976-03-23 Stanford Research Institute 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
BE1010266A4 (nl) 1996-04-15 1998-04-07 Option International Aanpassingseenheid voor datatransmissie tussen een mobiele telefoon en een gegevensterminal.
PL331357A1 (en) 1996-07-23 1999-07-05 Pherin Pharmaceuticals Steroids as neurochemical vno stimulators for soothing the symptoms of premenstrual tension and anxiety

Also Published As

Publication number Publication date
ATE374613T1 (de) 2007-10-15
EP1244458A2 (en) 2002-10-02
WO2001049280A2 (en) 2001-07-12
EP1244458B1 (en) 2007-10-03
AU2463301A (en) 2001-07-16
JP2003519179A (ja) 2003-06-17
CA2394079C (en) 2009-09-29
DE60036640D1 (de) 2007-11-15
AR027136A1 (es) 2003-03-12
WO2001049280A3 (en) 2002-05-02
CA2394079A1 (en) 2001-07-12
ES2292495T3 (es) 2008-03-16
MXPA02006568A (es) 2003-10-15
US6555531B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
DE69507493T2 (de) Tirilazad parentale formulierung mit einem co-lösungsmittel
DE69327585T2 (de) Befruchtete muscheleier enthaltende zusammensetzung
DE69828881T2 (de) Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen
EP0796103B1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE60111025T2 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
DE69926804T2 (de) Vorrichtungen zur behandlung und diagnose des restless leg syndroms
DE68908117T2 (de) N-Acetylglukosamin als zytoprotektives Mittel.
EP0514328A1 (de) Chenodeoxycholsäure oder Ursodeoxycholsäure zur Behandlung von Erkrankungen der Atmungsorgane
DE69832250T2 (de) Glycosyl-Vitamin P als neuro-funktioneller Regulator
DE2824165A1 (de) Arzneimittel mit angstneurosen und angstaehnliche neurosen beseitigender wirkung und verfahren zum zubereiten des arzneimittels
DE69333290T2 (de) Estrensteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate
DE60036640T2 (de) Mittel zum stimulieren von körpergewichtzunahme, verfahren und produkt
DE69923988T2 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta-estern desselben
DE60020833T2 (de) Melatonin zur behandlung von paralysen ausgelöst durch hirnschlag
DE602004003173T2 (de) Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung
DE602005000442T2 (de) Verwendung von alpha-1-Antitrypsin zur Herstellung eines Medikaments zur Behandlung von Fibromyalgie
DE102017119313B4 (de) Gallensäure enthaltendes appetitzügelndes Mittel
DE102004063363A1 (de) Capsaicin-haltige Arzneien zur Behandlung von Bronchial-Infekten und Allergien
DE2633891A1 (de) Neues salz der alpha-methylbenzoyl- 5-thiophen-2-essigsaeure, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
EP0720854A1 (de) Verwendung von Gallensäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen der Haut
Omura Excessive Use of Steroid Hormone & Beneficial Effects of True ST. 36 Acupuncture on Malignant Brain Tumors--Part I; How to Estimate Non-Invasively Presence of Excess Dose of Steroid Hormone in Patients, Baseball Players & Other Professional Athletes from its Toxic Effects on Heart & Pancreas, as well as Persistent or Recurrent Infection--Part II
DE4326948C1 (de) Verwendung von natürlichen Östrogenen zur Verlangsamung des Alterungsprozesses bei Männern
DE2544061A1 (de) Pharmazeutische zubereitung iii
DE10248601A1 (de) Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
EP0597071A1 (de) Androgene zur stimulierung des zentralnervensystems und zur osteoporosebehandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition